Galmed Pharmaceuticals Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Galmed Pharmaceuticals Ltd
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
/ 
Frequently asked questions
To buy Galmed Pharmaceuticals Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Galmed Pharmaceuticals Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Galmed Pharmaceuticals Ltd is GLMD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Galmed Pharmaceuticals Ltd has its primary listing on NASDAQ (Small cap). You can trade Galmed Pharmaceuticals Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Galmed Pharmaceuticals Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Galmed Pharmaceuticals Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Galmed Pharmaceuticals Ltd.